BioLargo EPS - Earnings per Share 2010-2024 | BLGO
BioLargo eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| BioLargo Annual EPS |
| 2023 |
$-0.02 |
| 2022 |
$-0.02 |
| 2021 |
$-0.03 |
| 2020 |
$-0.05 |
| 2019 |
$-0.08 |
| 2018 |
$-0.09 |
| 2017 |
$-0.10 |
| 2016 |
$-0.09 |
| 2015 |
$-0.06 |
| 2014 |
$-0.05 |
| 2013 |
$-0.04 |
| 2012 |
$-0.08 |
| 2011 |
$-0.07 |
| 2010 |
$-0.13 |
| 2009 |
$-0.37 |
| BioLargo Quarterly EPS |
| 2024-09-30 |
$-0.00 |
| 2024-06-30 |
$-0.00 |
| 2024-03-31 |
$-0.00 |
| 2023-12-31 |
$-0.01 |
| 2023-09-30 |
$-0.00 |
| 2023-06-30 |
$-0.01 |
| 2023-03-31 |
$-0.00 |
| 2022-12-31 |
$-0.00 |
| 2022-09-30 |
$0.00 |
| 2022-06-30 |
$-0.01 |
| 2022-03-31 |
$-0.01 |
| 2021-12-31 |
$0.00 |
| 2021-09-30 |
$-0.01 |
| 2021-06-30 |
$-0.01 |
| 2021-03-31 |
$-0.01 |
| 2020-12-31 |
$-0.02 |
| 2020-09-30 |
$-0.01 |
| 2020-06-30 |
$-0.01 |
| 2020-03-31 |
$-0.01 |
| 2019-12-31 |
$-0.03 |
| 2019-09-30 |
$-0.02 |
| 2019-06-30 |
$-0.01 |
| 2019-03-31 |
$-0.02 |
| 2018-12-31 |
$-0.02 |
| 2018-09-30 |
$-0.02 |
| 2018-06-30 |
$-0.03 |
| 2018-03-31 |
$-0.02 |
| 2017-12-31 |
$-0.03 |
| 2017-09-30 |
$-0.02 |
| 2017-06-30 |
$-0.03 |
| 2017-03-31 |
$-0.02 |
| 2016-12-31 |
$-0.02 |
| 2016-09-30 |
$-0.03 |
| 2016-06-30 |
$-0.02 |
| 2016-03-31 |
$-0.02 |
| 2015-12-31 |
$-0.01 |
| 2015-09-30 |
$-0.02 |
| 2015-06-30 |
$-0.02 |
| 2015-03-31 |
$-0.01 |
| 2014-12-31 |
$-0.02 |
| 2014-09-30 |
$-0.01 |
| 2014-06-30 |
$-0.01 |
| 2014-03-31 |
$-0.01 |
| 2013-12-31 |
$-0.01 |
| 2013-09-30 |
$-0.01 |
| 2013-06-30 |
$-0.01 |
| 2013-03-31 |
$-0.01 |
| 2012-12-31 |
$-0.02 |
| 2012-09-30 |
$-0.01 |
| 2012-06-30 |
$-0.03 |
| 2012-03-31 |
$-0.02 |
| 2011-12-31 |
$-0.01 |
| 2011-09-30 |
$-0.01 |
| 2011-06-30 |
$-0.02 |
| 2011-03-31 |
$-0.03 |
| 2010-12-31 |
$-0.02 |
| 2010-09-30 |
$-0.03 |
| 2010-06-30 |
$-0.03 |
| 2010-03-31 |
$-0.05 |
| 2009-12-31 |
$-0.25 |
| 2009-09-30 |
$-0.04 |
| 2009-06-30 |
$-0.04 |
| 2009-03-31 |
$-0.04 |
| Sector |
Industry |
Market Cap |
Revenue |
| Construction |
Engineering - Research & Development Services |
$0.054B |
$0.012B |
|
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
|
